Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Psychemedics (NQ: PMD )

2.290 -0.060 (-2.55%)
Streaming Delayed Price Updated: 2:39 PM EDT, Jun 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Psychemedics

Psychemedics Corporation Reports First Quarter 2024 Financial Results
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Reports 2023 Financial Results
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
From Psychemedics Corporation
Via GlobeNewswire
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
Psychemedics’ FDA-cleared alternative 5-panel drug screen replaces marijuana with fentanyl. 
From Psychemedics Corporation
Via GlobeNewswire
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
From Psychemedics Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.